Last edition
News about "Japan Pharmaceuticals and Medical Devices Agency"
GlycoNex Submits Denosumab Biosimilar SPD8 for Regulatory Approval in Japan
Subject to regulatory review and approval, SPD8 could receive marketing approval in Japan by the end of 2027, paving the way for its commercial launch.
Japan Pharmaceuticals And Medical Devices Agency | 09/11/2026 | By Abha Rustagi
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members